Expression of Granzyme B in Viral Hepatitis in Patients with ALPS [2]

Hepatology

Volumn 39, Issue 3, 2004, Pages 864-865

  André, Nicolas ^a   Roquelaure, Bertrand ^b   Thuret, Isabelle ^b   Ziol, Marianne ^c   Rieux Laucat, Frédéric ^d   Le Deist, Françoise ^e  

^a CNRS   (France)

^b TIMONE HOSPITAL   (France)

^c J Verdier University Hospital   (France)

^d INSERM   (France)

^e Necker Enfants Malades   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GRANZYME B;

ADOLESCENT; ADULT; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; GENE OVEREXPRESSION; GENETIC CODE; HUMAN; HUMAN TISSUE; LETTER; LIVER BIOPSY; LYMPHOCYTE COUNT; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; T LYMPHOCYTE ACTIVATION; VIRUS HEPATITIS;

AUTOIMMUNE DISEASES; GRANZYMES; HEPATITIS, VIRAL, HUMAN; HUMANS; LYMPHOPROLIFERATIVE DISORDERS; SERINE ENDOPEPTIDASES; SYNDROME;

EID: 1542619636     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20100     Document Type: Letter

References (6)

1. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferative syndromes: genetic defects of apoptosis pathways. Cell Death Differ 2003;10:124-133.
2. Le Deist F, Emile JF, Rieux-Laucat F, Benkerrou M, Roberts I, Brousse N, Fisher A, et al. Clinical, immunological, and pathological consequences of Fas-deficient conditions. Lancet 1996;348:719-723.
3. Rieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995;268:1347-1349.
4. Pensati L, Costanzo A, Ianni A, Accapezzato D, Iorio R, Natoli G, Nisini R, et al. Fas/APO1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 1997;113:1384-1389.
5. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S. Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997;3:409-413.
6. Czaja A, Homburger HA. Autoantibodies in liver disease. Gastroenterology 2001;120:239-249.